ISSN 1006-298X      CN 32-1425/R

导航

肾脏病与透析肾移植杂志 ›› 2013, Vol. 22 ›› Issue (5): 461-465.

• 论文 • 上一篇    下一篇

IgA肾病牛津分类及验证研究

  

  • 出版日期:2013-10-28 发布日期:2013-10-28

Oxford Classi?cation of IgA Nephropathy and the Validation Studies

  • Online:2013-10-28 Published:2013-10-28

摘要:

摘要 IgA肾病(IgA nephropathy,IgAN)是一种常见的慢性肾小球肾炎,也是导致终末期肾病(end-stage renal disease,ESRD)的常见病因。近年来IgAN在病理分型、影响预后的危险因素方面研究不断。2009年由国际IgAN协作组发表的牛津分类是最新的病理分类,该分类提出了系膜细胞增生积分(M)、节段肾小球硬化或黏连(S)、毛细血管内细胞增生(E)、肾小管萎缩/间质纤维化(T)这四个可能预测患者预后的病理指标。虽然IgAN牛津分类研究是一项多中心研究,但是纳入病例数限,忽略了急性进展及临床表现轻微的病例。自该病理分类提出后,世界各地不少研究对该病理分类能否反映疾病预后进行了验证。回顾已发表的15个验证研究,T是能反映IgAN预后差的有力的病理指标,M、E、S的预测价值仍存在争议。少数研究纳入了病情急性进展的病例,结果显示细胞性或细胞纤维性新月体(C)与预后差相关。2个研究指出伴E、C病变的患者在免疫抑制治疗后预后好。

Abstract:

ABSTRACT   IgA nephropathy (IgAN) is a common chronic glomerulonephritis that leads to end-stage renal disease (ESRD). There are a lot of studies on histological classi?cation in recent years. The Oxford classi?cation of IgAN published at 2009 is the newest one. It provides four histopathological indicators which may be associated with kidney disease outcomes. They are the mesangial hypercellularity score (M), endocapillary hypercellularity (E), segmental glomerulosclerosis(S) and tubular atrophy/interstitial fibrosis (T). Though it was a multicenter study, the number of patients in the Oxford classi?cation research was limited, and the classification excluded very mild and very acute cases. Since the classi?cation was published, there have been many studies on whether these pathological features are applicable to predict prognosis. Review the 15 recent validation studies, T has the close relationship with the poor outcome,but the prognostic values of M, E, S are still arguable. Few researches included patients with rapidly progressive disease find cellular or fibrocellular crescents (C) may be a prognostic marker. 2 validation studies have showed that E, C lesions are responsive to immunosuppressive therapy.